IGM Biosciences CEO Fred Schwarzer's 2021 pay jumps 94% to $9.9M
IGM Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 27, 2023
IGM Biosciences reported fiscal year 2021 executive compensation information on April 27, 2023.
In 2021, four executives at IGM Biosciences received on average a compensation package of $6.9M, a 106% increase compared to previous year.
Average pay of disclosed executives at IGM Biosciences
Fred Schwarzer, Chief Executive Officer, received $9.9M in total, which increased by 94% compared to 2020. 85% of Schwarzer's compensation, or $8.4M, was in option awards. Schwarzer also received $329K in non-equity incentive plan, $598K in salary, as well as $600K in stock awards.
Chris H. Takimoto, M.D., Ph.D., F.A.C.P, Chief Medical Officer, received a compensation package of $8.5M. 88% of the compensation package, or $7.5M, was in option awards.
Lisa L. Decker, Chief Business Officer, earned $4.9M in 2021.
Bruce Keyt, Chief Scientific Officer, received $4.6M in 2021, which increases by 67% compared to 2020.
Related executives
You may also like
Source: SEC filing on April 27, 2023.